Category: SPACs

Upcoming Event: SPACs State of the Current Market + Enforcement Trends

Partners John McKenna and Luke Cadigan will join PwC to discuss SPACs, tax, audit, legal, and other relevant topics for finance and legal professionals at venture capital and private equity funds. This event will take place on Tuesday, June 22, 2021 at 11:00 AM PDT Click here to register for […]

Upcoming Event: Behind the Scenes of the 2021 IPO & SPAC Boom

Join Cooley, DFIN, PwC, Nasdaq and The Blueshirt Group for a two-part webinar series Behind the Scenes of the 2021 IPO & SPAC Boom on May 4 & 11, 2021. Hear the latest insights from leaders who have successfully completed recent IPOs or SPAC mergers and learn about the current capital raising […]

2020 TechGC SPAC Forum (Webinar)

SPACs and Direct Listings have emerged as a significant new liquidity path for high growth tech companies over the last several months. In this three-day virtual forum, we’ll discuss how to approach these liquidity events strategically including evaluating which structure to use, understanding economics / dilution, and how to execute […]

SPACs – The Next Generation of IPOs or Just a Fad? (Webinar)

Driven by ongoing market pressures brought on by the COVID-19 pandemic, we have seen a surge of interest in special purpose acquisition (SPAC) transactions from companies across sectors. During this session, we will hear from industry lawyers, exchange executives, and investment bankers on key considerations for navigating a SPAC merger, […]

Pacific Southwest Region SPAC / IPO Roundtable (Webinar)

The market continues to be active! Learn what has changed in navigating these unprecedented times. This roundtable is designed for C-Suite executives, accounting and finance leaders of pre-IPO companies. Cooley partners Dave Peinsipp and Sean Clayton, Deloitte, Nasdaq and an investment banker well-versed in the IPO and SPAC processes to […]

SPAC Transactions – Considerations for Target-Company CFOs

Although special-purpose acquisition companies (SPACs) have been used for decades as alternative investment vehicles, they have recently come into vogue as seasoned investors and management teams have turned to SPACs to mitigate the increased market volatility risk of traditional initial public offerings (IPOs). In fact, 2020 has been a record-breaking […]

A Couple of Quick Items Regarding IPO Alternatives

Here are two quick items regarding popular IPO alternatives, SPACs (special purpose acquisition corporations) and primary direct listings: SPACs.  In an interview on CNBC with Andrew Ross Sorkin on Thursday, SEC Chair Jay Clayton addressed the recent SPAC frenzy. (Very loosely, SPACs are companies with no real operations formed to […]

Dealmakers Roundtable: SPACs! (webinar) [UPDATED]

Feel like your newsfeed has exploded with press around SPACs? We can help cut through the hype. The Cooley team advising on many in-progress SPAC transactions will share a high-level overview of structure, key considerations and reasons SPACs are so popular. We’ll also attempt to answer the key question of […]

Cell & Gene Meeting on The Mesa (webinar)

The Cell & Gene Meeting on the Mesa is the sector’s foremost annual conference bringing together senior executives and top decision-makers in the industry to advance cutting-edge research into cures. This conference covers commercialization hurdles facing the cell and gene therapy sector as well as a wide range of topics […]

Bay Area IPO Readiness Workshop (webinar)

Cooley partner Dave Peinsipp, Deloitte and leaders from other organizations well-versed in the IPO, direct listing and SPAC processes share their insights on the next normal. Topics include Current market conditions Regulatory considerations How to prepare for the IPO process Life as a public company Actionable insights from a CFO/controller […]